| Cash Flow | 2025-06-30 |
|---|---|
| Net loss for the period | -197,929 |
| Amortization of right-of-use assets | 29,663 |
| Interest expense | -4,447 |
| Prepaid expenses | 5,110 |
| Lease liabilities | -29,048 |
| Accounts payable | -4,731 |
| Interest payable | 4,447 |
| Accrued expenses | -4,553 |
| Other current assets | 228,321 |
| Net cash provided by (used in) operating activities | -440,029 |
| Issuance of common stock | 0 |
| Issuance of preferred stock | 0 |
| Loan from shareholders | 400,000 |
| Net cash provided by financing activities | 400,000 |
| Net increase (decrease) in cash | -40,029 |
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (CURX)